Results 131 to 140 of about 3,063,172 (298)

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Receiver operating characteristic (ROC) analysis.

, 2015
Receiver operating characteristic (ROC) analysis showing the discrimination of healthy controls (n = 44) from PAH patients ((IPAH and CTD-PAH); n = 95) cohorts.
Caroline O’Connell (719581), Allison Morton (719583), Sean Gaine (719587), Robin Condliffe (719585), Mary Codd (719582), Christine M. Costello (719580), David G. Kiely (719584), Lili Li (42450), Allan Lawrie (276358), Charles Elliot (719586), Brian N. McCullagh (719579), Paul McLoughlin (494617)   +11 more
core   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

The receiver operating characteristic (ROC) curve

Southwest Respiratory and Critical Care Chronicles, 2017
Shengping Yang, Gilbert Berdine
doaj   +1 more source

Receiver Operating Characteristic Curve Analysis.

, 2014
LF: Ligamentum flavum; ES: Epidural Space; AUC: Area under curve; CI confidence interval.Receiver Operating Characteristic Curve Analysis.
Cihun-Siyong Alex Gong (622274), Shih-Pin Lin (491539), Mei-Yung Tsou (622276), Chien-Kun Ting (622278), M. Susan Mandell (622275), Yin Chang (622277)   +5 more
core   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Determination of Sexual Dimorphism of the Human Sacrum Based on Receiver Operating Characteristic Curve Analysis of Morphometric Parameters. [PDF]

Cureus, 2023
Saluja S, Tigga SR, Das SS, Thakur A.
europepmc   +1 more source

Analysis of Receiver Operating Characteristic Curves for Cure Survival Data and Mismeasured Biomarkers

Mathematics
Cure models and receiver operating characteristic (ROC) curve estimation are two important issues in survival analysis and have received attention for many years.
Li-Pang Chen
doaj   +1 more source

Receiver operating characteristic curve analysis.

, 2016
Receiver operating characteristic curve analysis of stereology (3 analysts) and HepaFat-Scan (3 analysts) for prediction of hepatopathologists’ steatosis gradings in biopsies.
Michael J. House (392724), Tim G. St. Pierre (217460), Andrew Clouston (228391), Andrew Bathgate (2921457), John K. Olynyk (392730), Sander J. Bangma (392728), Prithi S. Bhathal (392729), Oyekoya T. Ayonrinde (392727), Wenjie Pang (2921460), Eng K. Gan (392725), Leon A. Adams (392726)   +10 more
core   +1 more source

Translating whole‐genome doubling into precision medicine in cancer

Molecular Oncology, EarlyView.
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley   +1 more source